Results
|
|
381.
|
|
|
|
382.
|
|
|
|
383.
|
|
|
|
384.
|
|
|
|
385.
|
|
|
|
386.
|
|
|
|
387.
|
|
|
|
388.
|
|
|
|
389.
|
|
|
|
390.
|
|
|
|
391.
|
|
|
|
392.
|
|
|
|
393.
|
|
|
|
394.
|
|
|
|
395.
|
|
|
|
396.
|
|
|
|
397.
|
|
|
|
398.
|
|
|
|
399.
|
|
|
|
400.
|
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. [electronic resource] by
- Kehne, J H
- Baron, B M
- Carr, A A
- Chaney, S F
- Elands, J
- Feldman, D J
- Frank, R A
- van Giersbergen, P L
- McCloskey, T C
- Johnson, M P
- McCarty, D R
- Poirot, M
- Senyah, Y
- Siegel, B W
- Widmaier, C
Producer: 19960627
In:
The Journal of pharmacology and experimental therapeutics vol. 277
Availability: No items available.
|